Ligand (LGND) will also provide an updated 5-year outlook: Long-term royalty receipts expected to deliver at least a 23% compound annual growth rate; Existing commercial programs and late-stage pipeline support royalty revenue CAGR of 20%
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LGND: